Cargando…

Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases

The monoamine model of depression has long formed the basis of drug development but fails to explain treatment resistance or associations with stress or inflammation. Recent animal research, clinical trials of ketamine (a glutamate receptor antagonist), neuroimaging research, and microbiome studies...

Descripción completa

Detalles Bibliográficos
Autores principales:	McGrath, Thomas, Baskerville, Richard, Rogero, Marcelo, Castell, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912368/ https://www.ncbi.nlm.nih.gov/pubmed/35267893 http://dx.doi.org/10.3390/nu14050917

Ejemplares similares

The effects of physical activity on glutamate neurotransmission in neuropsychiatric disorders
por: Baskerville, Richard, et al.
Publicado: (2023)

Glutamatergic Dysfunction and Glutamatergic Compounds for Major Psychiatric Disorders: Evidence From Clinical Neuroimaging Studies
por: Li, Cheng-Ta, et al.
Publicado: (2019)

Glutamatergic dysfunction in Schizophrenia
por: Kruse, Andreas O., et al.
Publicado: (2022)

Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings
por: Le, Tram T., et al.
Publicado: (2022)

Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders
por: Cuttler, Katelyn, et al.
Publicado: (2021)

Magnetic Resonance Spectroscopy in Schizophrenia: Evidence for Glutamatergic Dysfunction and Impaired Energy Metabolism
por: Duarte, João M. N., et al.
Publicado: (2018)

The emerging role of furin in neurodegenerative and neuropsychiatric diseases
por: Zhang, Yi, et al.
Publicado: (2022)

Emerging Roles of FTO in Neuropsychiatric Disorders
por: Chang, Rui, et al.
Publicado: (2022)

Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder
por: Ting, Jonathan T, et al.
Publicado: (2008)

The role of algorithms in guiding emergency airway management
por: McGrath, B. A., et al.
Publicado: (2021)

The Emergent Role of Virtual Reality in the Treatment of Neuropsychiatric Disease
por: Benyoucef, Yacine, et al.
Publicado: (2017)

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
por: Nashed, Mina G., et al.
Publicado: (2021)

Chronic HCV infection and neuropsychiatric dysfunction
por: Fortini, Ida, et al.
Publicado: (2019)

In vivo effects of antibodies from patients with anti-NMDA receptor encephalitis: further evidence of synaptic glutamatergic dysfunction
por: Manto, Mario, et al.
Publicado: (2010)

Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies
por: Eltokhi, Ahmed, et al.
Publicado: (2020)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Up in the Air: The Emerging Science of Dust and Sandstorm Microbes
por: McGrath, Casey
Publicado: (2018)

Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model
por: Pan, Hong, et al.
Publicado: (2018)

The Impact of Glutamatergic Synapse Dysfunction in the Corticothalamocortical Network on Absence Seizure Generation
por: Leitch, Beulah
Publicado: (2022)

Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy
por: Arouche-Delaperche, L., et al.
Publicado: (2023)

Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
por: He, Jin-Gang, et al.
Publicado: (2022)

Glutamatergic dysfunction, neuroplasticity, and redox status in patients with functional movement disorders
por: Demartini, B., et al.
Publicado: (2023)

Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
por: Cacabelos, Ramon
Publicado: (2020)

Editorial: Temporal lobe dysfunction in neuropsychiatric disorder
por: Gao, Yujun, et al.
Publicado: (2022)

The Biology of the Glutamatergic System and Potential Role in Migraine
por: Gasparini, C. F., et al.
Publicado: (2013)

Possible Compensatory Role of ASICs in Glutamatergic Synapses
por: Evlanenkov, Konstantin K., et al.
Publicado: (2023)

Key role of the dopamine D(4) receptor in the modulation of corticostriatal glutamatergic neurotransmission
por: Bonaventura, Jordi, et al.
Publicado: (2017)

The Role of Gut Microbiota in Neuropsychiatric Diseases – Creation of An Atlas-Based on Quantified Evidence
por: Bonnechère, Bruno, et al.
Publicado: (2022)

Neuroadaptations and TGF-β Signaling: Emerging role in models of neuropsychiatric disorders
por: Mitra, Swarup, et al.
Publicado: (2022)

Role of Ca(2+)/Calmodulin-Dependent Protein Kinase Type II in Mediating Function and Dysfunction at Glutamatergic Synapses
por: Mohanan, Archana G., et al.
Publicado: (2022)

Glutamatergic dysfunction in resistant obsessive-compulsive disorder: An auditory mismatch negativity study
por: Syed, F., et al.
Publicado: (2021)

Glutamatergic Synapse Dysfunction in Drosophila Neuromuscular Junctions Can Be Rescued by Proteostasis Modulation
por: Chakravorty, Anushka, et al.
Publicado: (2022)

Glutamatergic Neurons Induce Expression of Functional Glutamatergic Synapses in Primary Myotubes
por: Ettorre, Michele, et al.
Publicado: (2012)

Executive Dysfunctions: The Role in Attention Deficit Hyperactivity and Post-traumatic Stress Neuropsychiatric Disorders
por: Martínez, Lía, et al.
Publicado: (2016)

Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders
por: Guidotti, Alessandro, et al.
Publicado: (2016)

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders
por: Morris, Gerwyn, et al.
Publicado: (2015)

mTOR-Related Brain Dysfunctions in Neuropsychiatric Disorders
por: Ryskalin, Larisa, et al.
Publicado: (2018)

Brain Metabolic Dysfunction in Early Neuropsychiatric Symptoms of Dementia
por: Ng, Kok Pin, et al.
Publicado: (2019)

Role of nucleus accumbens glutamatergic plasticity in drug addiction
por: Quintero, Gabriel C
Publicado: (2013)

Inflammation in stroke: the role of cholinergic, purinergic and glutamatergic signaling
por: Martín, Abraham, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b6n0n7fe6jnqrqgafk59e67iqj